Tetraphase Pharmaceuticals Inc (TTPH.OQ)
TTPH.OQ on NASDAQ Stock Exchange Global Select Market
1.29USD
2:29am IST
1.29USD
2:29am IST
Change (% chg)
$-0.10 (-7.19%)
$-0.10 (-7.19%)
Prev Close
$1.39
$1.39
Open
$1.39
$1.39
Day's High
$1.40
$1.40
Day's Low
$1.28
$1.28
Volume
241,452
241,452
Avg. Vol
165,563
165,563
52-wk High
$6.59
$6.59
52-wk Low
$1.01
$1.01
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 1.15 | -0.369 |
| Jun '18 | 11.58 | -0.184 | |
| Mar '18 | 1.89 | -0.418 | |
| FY 2017 | Dec '17 | 2.53 | -0.456 |
| Sep '17 | 4.07 | -0.634 | |
| Jun '17 | 1.59 | -0.831 | |
| Mar '17 | 1.49 | -0.794 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 4 | 2.34 | 2.85 | 1.90 | -- |
| Quarter Ending Jun-19 | 4 | 2.93 | 3.60 | 1.75 | -- |
| Year Ending Dec-19 | 7 | 19.11 | 33.50 | 11.00 | 29.20 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 4 | -0.31 | -0.18 | -0.41 | -2.20 |
| Quarter Ending Jun-19 | 4 | -0.31 | -0.19 | -0.43 | -1.46 |
| Year Ending Dec-19 | 7 | -1.22 | -0.77 | -1.63 | -1.61 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 30.48 | 33.71 | |
| P/E High - Last 5 Yrs. | -- | 45.02 | 49.93 | |
| P/E Low - Last 5 Yrs. | -- | 23.66 | 24.27 | |
| Beta | 2.59 | 0.90 | 0.90 | |
| Price to Sales (TTM) | 79.06 | 4.12 | 6.28 | |
| Price to Book (MRQ) | 2.90 | 5.11 | 5.27 | |
| Price to Tangible Book (MRQ) | 3.70 | 5.85 | 6.79 | |
| Price to Cash Flow (TTM) | -- | 24.01 | 24.84 | |
| % Owned Institutions | 46.51 | 0.91 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.49 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 1.51 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 4.13 | 4.83 | |
| Payout Ratio(TTM) | -- | 43.96 | 41.08 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 27.59 | 4.30 | 9.72 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -41.27 | 4.14 | 5.87 | |
| Sales - 5 Yr. Growth Rate | 94.47 | 10.87 | 11.20 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -77.33 | 45.04 | 47.26 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -46.60 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 10.28 | 10.82 | |
| Capital Spending - 5 Yr. Growth Rate | 43.32 | 15.84 | 15.18 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.15 | 2.26 |
| Current Ratio (MRQ) | 6.12 | 2.98 | 3.08 |
| LT Debt to Equity (MRQ) | 0.00 | 8.86 | 11.38 |
| Total Debt to Equity (MRQ) | 0.00 | 12.90 | 16.13 |
| Interest Coverage (TTM) | -371.75 | 33.85 | 29.51 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 53.65 | 53.78 | |
| Gross Margin - 5 Yr. Avg. | -- | 51.65 | 52.17 | |
| EBITD Margin (TTM) | -2,095.27 | -- | -- | |
| EBITD - 5 Yr. Avg | -608.22 | 17.95 | 12.87 | |
| Operating Margin (TTM) | -2,102.20 | 14.28 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | -610.67 | 14.22 | 8.31 | |
| Pre-Tax Margin (TTM) | -2,092.20 | 14.84 | 7.17 | |
| Pre-Tax Margin - 5 Yr. Avg. | -618.28 | 14.67 | 8.61 | |
| Net Profit Margin (TTM) | -2,092.20 | 11.08 | 3.30 | |
| Net Profit Margin - 5 Yr. Avg. | -618.28 | 11.02 | 4.88 | |
| Effective Tax Rate (TTM) | -- | 23.02 | 22.88 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 23.17 | 23.39 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 75,924 | 959,798,954 | 844,239,694 | |
| Net Income/Employee (TTM) | -1,588,485 | 113,819,313 | 100,064,161 | |
| Receivable Turnover (TTM) | 1.77 | 5.72 | 5.72 | |
| Inventory Turnover (TTM) | -- | 2.61 | 3.48 | |
| Asset Turnover (TTM) | 0.03 | 0.97 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -66.47 | 11.55 | 11.08 | |
| Return on Assets - 5 Yr. Avg. | -49.48 | 12.93 | 12.21 | |
| Return on Investment (TTM) | -73.69 | 14.98 | 14.48 | |
| Return on Investment - 5 Yr. Avg. | -55.43 | 16.85 | 15.88 | |
| Return on Equity (TTM) | -73.76 | 16.31 | 15.99 | |
| Return on Equity - 5 Yr. Avg. | -77.07 | 17.77 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -55.97 | -21.13 | 94.47 |
| EPS (TTM) % | 10.52 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Tetraphase Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 12.79 | 8.90 | 99 | 22 |
| 13 Week | 8.08 | 2.81 | 99 | 39 |
| 26 Week | -6.62 | -13.72 | 99 | 33 |
| 52 Week | 105.29 | 74.00 | 99 | 9 |
| YTD | 92.56 | 69.10 | 99 | 26 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 43.99% |
| # of Holders: | 126 |
| Total Shares Held: | 23,589,400 |
| 3 Mo. Net Change: | -40,586 |
| # New Positions: | 0 |
| # Closed Positions: | 2 |
| # Increased Positions: | 1 |
| # Reduced Positions: | 8 |
| # Net Buyers: | -7 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.